Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · IEX Real-Time Price · USD
0.186
+0.006 (3.06%)
Apr 23, 2024, 10:20 AM EDT - Market open
MTNB Stock Forecast
MTNB's stock price has decreased by -73.37% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for MTNB stock has a target of 3.00, which predicts an increase of 1,517.25% from the current stock price of 0.19.
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 11, 2023.
Analyst Ratings
According to 1 stock analyst, the rating for MTNB is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
BTIG | BTIG | Strong Buy Initiates $3 | Strong Buy | Initiates | $3 | +1,517.25% | Oct 11, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +1,517.25% | Jan 31, 2023 |
Piper Sandler | Piper Sandler | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jan 27, 2020 |
SunTrust Robinson Humphrey | SunTrust Robinson Humphrey | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Jan 24, 2020 |
Maxim Group | Maxim Group | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Nov 13, 2018 |
Financial Forecast
Revenue This Year
n/a
from 1.10M
Revenue Next Year
n/a
EPS This Year
-0.12
from -0.11
EPS Next Year
-0.10
from -0.12
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | n/a | 29.7M | 77.0M |
Avg | n/a | n/a | n/a | 28.8M | 74.8M |
Low | n/a | n/a | n/a | 27.7M | 71.9M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | 167.2% |
Avg | - | - | - | - | 159.6% |
Low | - | - | - | - | 149.4% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -0.13 | -0.11 | -0.09 | -0.02 | 0.11 |
Avg | -0.12 | -0.10 | -0.09 | -0.02 | 0.10 |
Low | -0.12 | -0.10 | -0.09 | -0.02 | 0.10 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.